These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 3112710)
1. [In vitro study of the combination of pefloxacin with other antibiotics against Pseudomonas aeruginosa and Streptococcus group D]. Zuccarelli M; Attisso MA; Simeon de Buochberg M; Dusart G Pathol Biol (Paris); 1987 May; 35(5):581-5. PubMed ID: 3112710 [TBL] [Abstract][Full Text] [Related]
2. [Comparative bactericidal kinetics of ciprofloxacin, ofloxacin and pefloxacin alone and in combination against strains of group D Streptococcus]. Zuccarelli M; Simeon de Buochberg M; Maillols M; Armynot du Chatelet AM; Attisso MA Pathol Biol (Paris); 1988 May; 36(5):403-9. PubMed ID: 3136422 [TBL] [Abstract][Full Text] [Related]
3. [Comparative bacteriologic activity of norfloxacin, ofloxacin and pefloxacin against 320 Gram-negative bacilli resistant and non-resistant to nalidixic acid and cephalosporins]. Croize J; Le Noc P; Bryskier A; Robert J Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):564-8. PubMed ID: 3937128 [TBL] [Abstract][Full Text] [Related]
4. N-formimidoyl-thienamycin and norfloxacin against multiple-resistant Pseudomonas aeruginosa strains. Combined in vitro activity and comparison with 14 other antibiotics. Martino P; Venditti M; Valente B; Brandimarte C; Serra P Drugs Exp Clin Res; 1985; 11(4):247-51. PubMed ID: 3939121 [TBL] [Abstract][Full Text] [Related]
5. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units. Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562 [TBL] [Abstract][Full Text] [Related]
6. [Study of the sensitivity to pipemidic acid, pefloxacin and norfloxacin of 444 bacterial strains isolated at a general hospital]. Berardi-Grassias LD; Roy O Pathol Biol (Paris); 1987 May; 35(5):467-72. PubMed ID: 3112705 [TBL] [Abstract][Full Text] [Related]
7. Comparative in vitro activity of ciprofloxacin, ofloxacin and pefloxacin against resistant clinical isolates. Periti P; Mazzei T; Nicoletti P Chemioterapia; 1987 Apr; 6(2):75-8. PubMed ID: 3474081 [TBL] [Abstract][Full Text] [Related]
8. In-vitro activity of pefloxacin against micro-organisms multiply resistant to beta-lactam antibiotics and aminoglycosides. Verbist L J Antimicrob Chemother; 1986 Apr; 17 Suppl B():11-7. PubMed ID: 3086278 [TBL] [Abstract][Full Text] [Related]
9. The comparative in-vitro activity of pefloxacin. King A; Phillips I J Antimicrob Chemother; 1986 Apr; 17 Suppl B():1-10. PubMed ID: 2940213 [TBL] [Abstract][Full Text] [Related]
10. [Group D streptococci and enterococci: identification, sensitivity to antibiotics and a study of the high level resistance to aminosides (Charles Nicolle Hospital in Tunis)]. Kechrid A; Ben Redjeb S; Gargouri J; Fendri C; Ben Hassen E; Boujnah A Med Trop (Mars); 1991; 51(2):177-80. PubMed ID: 1910140 [TBL] [Abstract][Full Text] [Related]
11. [Combined in vitro effect of new betalactam antibiotics and aminoglycosides against Pseudomonas aeruginosa ]. Thabaut A; Durosoir JL; Meyran M Pathol Biol (Paris); 1982 Jun; 30(6 Pt 2):549-54. PubMed ID: 6812006 [TBL] [Abstract][Full Text] [Related]
12. [In vitro activity of 4 fluoroquinolones against Klebsiella pneumoniae. Distribution according to phenotype resistance to aminoglycosides or beta-lactams]. Miguères ML; Ronco E; Guenounou M Pathol Biol (Paris); 1990 May; 38(5):385-9. PubMed ID: 2195447 [TBL] [Abstract][Full Text] [Related]
13. [In vitro study of the pefloxacine-ceftriaxone combination against 18 strains of Acinetobacter]. Berardi-Grassias L; Bigel ML; Macheboeuf F; Boisivon A; Chauvière P; Guiomar C Pathol Biol (Paris); 1986 May; 34(5):436-9. PubMed ID: 3534716 [TBL] [Abstract][Full Text] [Related]
14. In-vitro activity of pefloxacin compared to other antibiotics. Yourassowsky E; Van der Linden MP; Crokaert F; Glupczynski Y J Antimicrob Chemother; 1986 Apr; 17 Suppl B():19-28. PubMed ID: 3086279 [TBL] [Abstract][Full Text] [Related]
15. [In vitro antibacterial activity of 2 new quinolones: A 56619 (difloxacin) and A 56620. Comparison with pefloxacin, ofloxacin and ciprofloxacin]. Soussy CJ; Deforges L; Le Van Thoi J; Duval J Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):759-67. PubMed ID: 3309811 [TBL] [Abstract][Full Text] [Related]
16. [Comparative in vitro susceptibility of clinical bacterial isolates to pefloxacin and 14 antibiotics]. Dolna I; Ruczkowska J; Chomontowicz M Przegl Lek; 1992; 49(7):213-5. PubMed ID: 1297147 [TBL] [Abstract][Full Text] [Related]
17. Pseudomonas aeruginosa isolates from different medical institutions. Nitzan Y; Sharon R; Maayan M; Steuerman C Isr J Med Sci; 1985 Oct; 21(10):798-803. PubMed ID: 3935600 [TBL] [Abstract][Full Text] [Related]
18. Ticarcillin-tobramycin-rifampin: in vitro synergy of the triplet combination against Pseudomonas aeruginosa. Zuravleff JJ; Yu VL; Yee RB J Lab Clin Med; 1983 Jun; 101(6):896-902. PubMed ID: 6406628 [TBL] [Abstract][Full Text] [Related]
19. Susceptibility of multiresistant serotype 012 Pseudomonas aeruginosa to fosfomycin in combination with other antibiotics. Watine J; Bourrel C; Dubourdieu B; Gineston JL; Bories P; Durand M; Marre A; Formosa F; Brunel MP; Palliez J Pathol Biol (Paris); 1994 Apr; 42(4):293-5. PubMed ID: 7808781 [TBL] [Abstract][Full Text] [Related]
20. [Comparison of the antimicrobial activity of pefloxacin (1589 RB), nalidixic acid and flumequin (author's transl)]. Thabaut A; Durosoir JL Pathol Biol (Paris); 1982 Jun; 30(6):394-7. PubMed ID: 6810283 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]